Phylonix Pharmaceuticals

Phylonix Pharmaceuticals is a biotechnology company that pioneered the use of zebrafish (Danio rerio) as a high-throughput model for drug discovery and safety assessment. The company provides specialized screening services to evaluate drug efficacy and toxicity in areas such as oncology, cardiovascular health, and the central nervous system. By utilizing the transparent embryos of zebrafish, Phylonix enables real-time visualization of biological processes and drug effects in a whole-animal system. Their platform serves as a bridge between in vitro assays and mammalian in vivo studies, helping to identify lead compounds and potential side effects early in the development process.